瘤变抑制因子14(ST14)单克隆抗体(生物素标记)
英文名称:Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
- 货号LAP657Hu72
- 物种Homo sapiens (Human)
- 实验方法Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.05-2ug/ml
Optimal working dilutions must be determined by end user.
- 反应时长
- 检测范围
- 灵敏度
- 样本类型
- 残基和标签
- 预测分子量
- 实际分子量
- 纯度
- 亚细胞定位
- 等电点
- 指标简称Suppression Of Tumorigenicity 14
- 指标别名SNC19; HAI; MT-SP1; PRSS14; TADG15; Epithin; Matriptase; Prostamin; Membrane-type serine protease 1; Serine protease 14; Tumor-associated differentially-expressed gene 15
- 缓冲液0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- 特点
- Tag
- 研究领域Tumor immunity;
- 引用
- 表达体系
- 宿主来源
- 应用WB; IHC; ICC.
- 网站链接http://www.cloud-clone.com/products/LAP657Hu72.html
- 说明书链接http://www.cloud-clone.com/manual/Biotin-Linked-Monoclonal-Antibody-to-Suppression-Of-Tumorigenicity-14-(ST14)-LAP657Hu72.pdf
- 规格200µl
- 曾用名
- 模式动物品系
- 实验分组
- 建模方法
- 模型评价
- 组织病理学
- 标志因子水平
- 样品类型
- 参考文献
- 品系
- 组织来源
- 生长状态
- 细胞类型
- 疾病
- 培养条件
- 浓度1mg/mL
- 免疫原MAP657Hu21-Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
- 性状Liquid
- 纯化方式Protein A + Protein G affinity chromatography
-
瘤变抑制因子14(ST14)单克隆抗体(生物素标记)